Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ad53b64eb74859acdc01278829b080 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9baa1e24cfefb75fcff756259a7eadf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66cc87061487cab00ae1de196919a322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be398b02f590028aa883a83be47b3d58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99288171296aef0574f4d354b224a373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72bc8cc75261eeae4b95d8de709e0d6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78eec8aedb2d2d62f95bd9cb63f0b4f1 |
publicationDate |
2012-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120115390-A |
titleOfInvention |
How to predict response to therapy of triple negative breast cancer |
abstract |
The present invention provides compositions and methods for detecting the level of expression and / or activation of signal transduction pathway components in tumor cells, such as triple negative metastatic breast tumor cells. Information about the level of expression and / or activation of signal transduction pathway components resulting from the use of the present invention can be used in cancer diagnosis, prognosis, and cancer treatment design. |
priorityDate |
2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |